We report seven patients with both myelodysplastic syndrome (MDS) and inflammatory bowel disease (IBD): Crohn's disease in six cases, ulcerative colitis in one case. We describe their characteristics, and those of 10 previously published similar cases are presented here. Median age at diagnosis of IBD (61 years) was high, as compared to the usual age at diagnosis of IBD. IBD was diagnosed first in nine cases, MDS first in one patient, and both diseases were diagnosed simultaneously in seven cases. Concerning IBD, there was a strong predominance of Crohn's disease (15/17 cases), with an unusually high frequency of colonic involvement (11/15 cases). MDS, in 12/17 cases, showed no excess of marrow blasts. Cytogenetic analysis was abnormal in five of the 13 evaluable cases. These observations suggest that the association between MDS and IBD may not be fortuitous in some cases, and that, in particular, patients with IBD and anemia of nonobvious origin should be evaluated for MDS. The pathogenesis of those associations, however, remains unclear.
Introduction
Myelodysplastic syndromes (MDS) are bone marrow stem cell disorders characterized by ineffective hematopoiesis leading to blood cytopenias, and by a high risk of progression to acute myeloid leukemia (AML). 1, 2 Several immunological disorders, particularly relapsing polychondritis, seronegative arthritis and cutaneous vasculitis have been described in association with MDS. 3 Crohn's disease and ulcerative colitis are inflammatory bowel diseases (IBD) characterized by inflammatory, ulcerative or not, lesions involving the small bowel and/or colon, and frequently associated with systemic manifestations. 4 Recently, a few patients with both IBD (Crohn's disease or ulcerative colitis) and MDS have been reported, and it was suggested that the association between the two disorders was not fortuitous. [5] [6] [7] [8] [9] [10] [11] [12] We report here seven additional cases associating MDS and IBD, and review previously published cases.
Case reports
Between 1982 and 1995, 845 cases of de novo MDS were diagnosed in the Hematology Department of the Centre Hospitalier Universitaire (CHU) of Lille. Four of them (0.55%) also had an IBD. Three additional patients (patient Nos 5, 6 and 7 presented in Table 1 ) with both MDS and IBD, diagnosed in other hospitals, were also analyzed.
Patient 1
A 52-year-old man presented in July 1987 with weight loss and diarrhea of 3 months duration. Blood counts revealed macrocytic anemia: hemoglobin 11.6 g/dl, MCV 105 fl, reticulocytes 25 × 10 9 /l, but white blood cell (WBC) and platelet counts were normal. There was no previous medical history. No alcohol consumption or liver disease (including B and C hepatitis) was found in this patient and in the other cases. Vitamin B12 and folate levels were normal. Erythrocyte sedimentation rate (ESR) was 50 mm/h, C reactive protein (CRP) was positive (24 mg/l). The bone marrow aspirate showed trilineage myelodysplasia, but no excess of blasts and no ringed cells, and a diagnosis of refractory anemia (RA) was made. The karyotype was normal. Xylose-D and Schilling tests were normal. Colonoscopy and ileoscopy showed petechial hemorrhages and ulcerations of the terminal ileum. Histological examination of biopsy specimens showed chorionic lymphoplasmacytic infiltration and ulcerations, diagnostic of Crohn's disease. The patient was treated by prednisolone 1 mg/kg/day. Diarrhea resolved after 2 weeks of treatment. Steroid dose was reduced and stopped after 4 months. In February 1992, the blood count, showing 6.2 × 10 9 /l WBC with monocytosis (2.0 × 10 9 /l) and bone marrow examination were diagnostic of chronic myelomonocytic leukemia (CMML). In May 1997, the patient received no specific therapy, and the digestive and hematological diseases were stable.
Patient 2
A 39-year-old woman presented in April 1994. She had history of diarrhea for 7 years but received no therapy. Blood counts revealed thrombocytopenia: platelet count 50 × 10 9 /l, and macrocytic anemia: hemoglobin 10.6 g/dl, MCV 102 fl, reticulocytes 42 × 10 9 /l, but the WBC count was normal. Vitamin B12 and folate levels were normal. The bone marrow aspirate showed trilineage myelodysplasia without excess of blasts or ringed cells, diagnostic of RA. The karyotype was normal. Ileoscopy showed ulcerations of the terminal ileum. Histological examination showed lymphoplasmacytic infiltration with epithelioid granuloma, diagnostic of Crohn's disease. The patient was treated by danazol 600 mg/day, resulting in an increase of platelet counts to 130 × 10 9 /l. She was also started on treatment with mesalazine 4 g/day and ciprofloxacine 800 mg/day. Diarrhea resolved after 1 month. In July 1995, relapse of the diarrhea was treated by the addition of prednisolone 1 mg/kg/day. In May 1997, the patient is still treated with danazol 300 mg/day and mesalazine 2 g/day. She has no digestive manifestations, and blood counts were stable.
Patient 3
A 62-year-old man presented in February 1992 with macrocytic anemia. He had a 10-year history of Crohn's disease involving the terminal ileum. The diagnosis has been based on the presence of diarrhea with weight loss, peri-anal abcesses and on histology, by inflammatory infiltrates with noncaseating granulomas containing epithelioid and giant cells. The patient had been initially treated with prednisolone for 4 years, and then with mesalazine 2 g/day for 2 years. The hemoglobin count was 10.2 g/l, MCV 109 fl, reticulocytes 25 × 10 9 /l. WBC and platelet counts were normal. Vitamin B12 and folate levels were normal. The bone marrow aspirate showed trilineage myelodysplasia without excess of blasts or ringed cells, leading to a diagnosis of RA. Macrocytic anemia was in fact already present in 1990, before the onset of mesalazine, and a bone marrow aspirate performed and considered normal. Review of this aspirate, however, showed that trilineage myelodysplasia was already present. Karyotype was normal. In February 1993, the disease progressed to CMML, but without excess of marrow blasts or high leukocyte counts (WBC, 4.8 × 10 9 /l; monocytes, 1.4 × 10 9 /l). In May 1997, the digestive and hematological diseases were stable (circulating monocytosis was 2.0 × 10 9 /l).
Patient 4
A 45-year-old man presented in July 1993 with diarrhea and digestive bleeding of 4 weeks duration. He had no medical history. Blood counts were normal. Barium enema showed loss of haustral pattern involving the whole colon. Colonoscopy showed diffuse erythema and ulcerations of the colon and the rectum. Histological examination showed ulcerations of the mucosae, inflammatory infiltrates, reduction of mucosae secretion and presence of cryptic abscesses, diagnostic of ulcerative colitis. Treatment with prednisolone 1 mg/kg/day was inactive, and subtotal colectomy with ileo-anal anastomosis was performed. In January 1996, blood counts showed leucocytosis (15 × 10 9 /l) with monocytosis (2.4 × 10 9 /l). Hemoglobin and platelet counts were normal. Bone marrow aspirate showed myelodysplastic features with 8% monocytes, confirming the diagnosis of CMML. The karyotype was normal. In May 1997, the digestive and hematological diseases were stable.
Patient 5
A 75-year-old woman presented in February 1994 with macrocytic anemia (hemoglobin, 10.1 g/dl; MCV, 115 fl). She had a history of hyperthyroidism and a 1-year history of diarrhea. The WBC and platelet counts were normal. The bone marrow aspirate showed trilineage myelodysplastic features with no excess of blasts but with numerous ringed sideroblasts (26%), leading to the diagnosis of RARS, in the absence of other causes of sideroblastic anemia. Vitamin B12 and folate levels were normal. In January 1995, pancytopenia developed and an excess of bone marrow blasts (27%) was found, showing evolution to RAEB-T. In April 1995, worsening of the diarrhea lead to colonoscopy, which showed diffuse inflammation of the anus and colon. Histological examination showed important chorionic inflammatory infiltrates in the chorion, diagnostic of Crohn's disease. A treatment with prednisolone was begun. The patient died in July 1995 from sepsis.
Patient 6
A 61-year-old man presented in March 1996 with diarrhea. He had a history of hypertension. Blood counts showed anemia (hemoglobin, 9.5 g/dl; MCV, 100 fl), but the platelet and WBC counts were normal. B12 and folate levels were normal. The bone marrow aspirate showed a trilineage myelodysplastic features with excess of blasts (7%), demonstrating RAEB. Colonoscopy showed ulcerations of the rectum and the colon. Histological examination showed inflammatory infiltrates involving colon and rectum, diagnostic of a Crohn's disease. The patient was treated with danazol 300 mg/day and mesalazine 4 g/day. In December 1996 treatment with prednisolone was started, due to headaches associated with inflammatory syndrome, suggestive of Horton's disease. The patient died 3 weeks later from heart failure.
Patient 7
An 80-year-old woman presented in December 1994 with anemia. She had a history of psoriasis and a 6-year history of Crohn's disease involving the colon and the anus. The diagnosis had been based on histological examination showing inflammatory infiltrates without granulomas, and the patient had been treated with prednisolone since diagnosis of Crohn's disease. The hemoglobin count was 8.5 g/l, and MCV 91 fl. The WBC was 4.9 × 10 9 /l, but with neutropenia (0.6 × 10 9 /l). The platelet count was 57 × 10 9 /l, and 11% circulating blasts were found. The bone marrow aspirate showed trilineage myelodysplasia with 15% of blasts, leading to a diagnosis of RAEB-T. Treatment with VP16 100 mg/day was started but without improvement of the hematological condition, and the patient died 4 weeks later.
Discussion
The association between MDS and IBD had previously been reported in 15 cases, to our knowledge, and 10 of these cases were reported in detail. [5] [6] [7] [8] [9] [10] Characteristics of those 10 cases, and of the seven cases presented here are shown in Table 1 .
Nine patients (53%) were male. Median age at the time of diagnosis of IBD and MDS was 61 (range, 28-87), and 66 years (range, 28-83), respectively. Five of the patients (29%) were aged less than 50, a somewhat atypical finding for MDS, which predominates in elderly patients. In our overall population of adult MDS, only 7% were aged less than 50. 13 By contrast, median age was higher than in usual series of IBD. 4 IBD was first diagnosed in nine patients in whom the median time interval between IBD and MDS diagnosis was 3 years (range, . MDS was first diagnosed in only one patient, 4 years before IBD diagnosis. Both diseases were diagnosed simultaneously in the remaining seven patients. IBD corresponded to Crohn's disease in 15 patients, ulcerative colitis in one case, and unclassified IBD in one case. Crohn's disease involved the small bowel, colon and both organs in four, eight, and three cases, respectively. This large incidence of colon involvement (11/15) is somewhat atypical for Crohn's disease. It might reflect the particularly old age of those patients, who had both Crohn's disease and MDS. Older age at onset of Crohn's disease is indeed associated with more frequent colonic involvement. 14 In northern France, the incidence of MDS in the general population is approximately 2 to 4/10 5 , 15 and the incidence of IBD is approximately 6/10 5 . 16 Estimation of the chance for a given person to have both disorders would require knowing their prevalence in our region, which we do not. However, several features of the patients analyzed here suggest a nonfortuitous association between MDS and IBD, at least for Crohn's disease: the relatively large number of patients with both MDS and IBD; the simultaneous occurrence of IBD and MDS in seven of the 17 reported cases; some unusual features of both MDS and IBD in those patients, including relatively old age of patients for Crohn's disease, but relatively young age for MDS, and the high incidence of colonic involvement in Crohn's disease. In addition, relapsing polychondritis, seronegative arthritis, and cutaneous vasculitis, which are not fortuitously associated to MDS, 17, 18 can also be observed in patients with IBD, mainly in Crohn's disease with colonic involvement in the case of seronegative arthritis and cutaneous vasculitis. 4 Also of note is that IBD are frequently associated with pyoderma gangrenosum, since the association between this cutaneous disorder and MDS is well recognised. 3 All these systemic, cutaneous, or digestive disorders associated with MDS are characterized by tissue damage with inflammatory infiltrates, without clear evidence of an autoimmune mechanism, and could be part of an abnormal immunological response against connective tissue components or infectious agents. Also of note is that a nonfortuitous association has been suggested between Crohn's disease and AML. 10 The pathogenesis of the association MDS-IBD remains unknown. Hypotheses to explain links between MDS and immunological disorders have recently been reviewed by Hamblin. 3 In this context, immunological disorders could result from MDS. MDS, principally CMML, can indeed be associated with high cytokine production, mainly of interleukins 1 and 6 and tumor necrosis factor ␣ (TNF␣), by malignant monocytes, and this could result in an abnormal lymphocytic response. Those cytokines, especially TNF␣, have also been implicated in the pathogenesis of Crohn's disease. 19 Lymphocytic impairment could also result from their being part of the abnormal dysplastic clone, but this probably occurs in only a small minority of MDS. On the other hand, a primary lymphocytic defect could participate in the emergence of clonal myeloid cells. In the case of the association between IBD and MDS, another hypothesis can also be made. Indeed, an infectious participation has been suggested in the pathogenesis of IBD. 4 MDS, because they are often associated with neutropenia and/or alterations of neutrophil functions, could lead to chronic bowel infections, and thereby increase the risk of IBD. Finally, environmental factors have recently been studied in the pathogenesis of MDS. It has been suggested that exposure to some chemical products, such as tobacco, may increase the risk of occurrence of MDS. 20 Tobacco is also the best documented environmental factor associated with Crohn's disease. 21 
